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I. ABSTRACT 
 
Background and Objectives 
Breast cancer has the highest incidence rates among women and is the 
second leading cause of death due to cancer in women. Of all breast cancers, triple 
negative breast cancer (TNBC) accounts for about one-fifth of breast cancer and 
tends to result in an aggressive form with larger tumors and rates of metastasis and 
is more frequently found in younger women. This results in an important need in 
information regarding the risk of diagnosis with triple negative breast cancer over 
other forms and covariates associated with death and TNBC. This paper studies the 
relationship between race, tobacco use, age, family history, marital status, insurance 
status, and menopausal status at diagnosis and the risk of mortality from TNBC.  
Methods 
Individual breast cancer patient data collected from the Kentucky Cancer 
Registry were analyzed to determine the association of potential risk factors with 
TNBC. The data was collected between 2009 and 2014 and contained individuals 
aged 18 or older that were diagnosed with breast cancer. Univariate and bivariate 
analysis were used to determine the characteristics of the study population. Logistic 
regression was used to determine the odds ratios for the covariates of interest in 
TNBC patients. Survival curves were used to compare survival for TNBC patients 
compared to all other breast cancer subtypes, and Cox proportional-hazard 
regression was used to determine the risk of death due to TNBC.  
 
 
	  
Results 
Significant increases in the odds for death due to TNBC were seen with 
women who were widowed (OR 1.53; 95% CI: 1.01, 2.33), on Medicare (OR 2.90; 
95% CI: 1.77, 4.74), uninsured (OR 3.84; 95% CI: 1.85, 8.00), or had a late stage at 
diagnosis (OR 9.462; 95% CI: 6.616, 13.531). These results are based on married 
women, privately insured women and women diagnosed at an early stage as the 
reference categories. There was a statistically significant difference between the 
survival curves for TNBC and all other subtypes (log-rank p<0.0001); patients with 
TNBC had a lower probability of survival than those with other breast cancer 
subtypes. TNBC patients that were single (HR: 1.63; 95% CI: 1.06, 2.50), on 
Medicaid (HR: 1.81; 95% CI: 1.13, 2.88), on Medicare (HR: 2.73; 95% CI: 1.77, 
4.20), uninsured (HR: 2.98; 95% CI: 1.57, 5.68), or diagnosed at a late stage (HR: 
6.54; 95% CI: 5.03, 8.49) had a significantly higher hazard of death when compared 
with patients who were married, patients that were privately insured and patients that 
were diagnosed at an early stage.  
Conclusions 
The study results show that marital and insurance status may be related to an 
increase of death due to TNBC. The results support findings from previous studies 
as well as expand upon previous studies by separating based on breast cancer 
subtype. Overall, continued screening can help with early diagnosis and treatment. 
Because TNBC is an aggressive subtype, early diagnosis and treatment may help 
reduce the mortality rates associated with TNBC. Further research examining the 
covariates used in the study is needed to reinforce the results found in this study.  
	  
II. INTRODUCTION 
 
Breast cancer is the most commonly diagnosed cancer in women in the United 
States, with more than 230,000 cases in 2013 (U.S. Cancer Statistics Working 
Group, 2016). In the United States, breast cancer is also the second leading cause 
of cancer death in women (U.S. Cancer Statistics Working Group, 2016). According 
the National Cancer Institute, breast cancer is defined as a cancer that forms in the 
tissues of the breast, and it is considered invasive if the breast cancer has spread 
from where it began to the surrounding tissue. Breast cancer is typically categorized 
by the presence or absence of human epidermal growth factor receptor 2 (HER2) 
and hormone-receptor expression (Elias, 2010). This paper will focus on triple 
negative breast cancer (TNBC) and possible predictors of this subtype of breast 
cancer. TNBC lacks HER2 amplification, progesterone receptor (PR) expression, 
and estrogen receptor (ER) expression (Reyes, et al., 2017).   
TNBC accounts for about 15%-20% of all cases of breast cancer (Reyes, et al., 
2017). It tends to be more aggressive than other subtypes of breast cancer, 
generally affects younger women, has been shown to have poorer 5-year survival 
rates, and has greater chances of metastases and recurrence than other forms of 
breast cancer (Elias, 2010; Reyes, et al., 2017; Kawai, et al, 2014). Because of the 
aggressive nature and higher likelihood of affecting younger women, understanding 
the sociodemographic and clinical predictors of TNBC is important. However, 
relatively few current publications focus on risk factors for TNBC versus other 
subtypes of breast cancer (Hudis, et al., 2011).  
	  
There are many known risk factors for breast cancer, but few have been 
examined related to specific subtypes of breast cancer, such as TNBC. Menopausal 
status, tobacco use, family history, and race are all associated with the risk of breast 
cancer (Kawai, et al., 2014; Howell, et al., 2014). This paper further examines these 
risk factors in terms of their association with TNBC. This paper will also examine 
whether marital status and insurance status are risk factors for TNBC. Married 
women have been shown to have lower mortality rates when compared with 
unmarried cancer patients (Martinez, et al., 2017). The main goal of this research is 
to determine which factors may be related to a higher risk of death in patients with 
TNBC. A secondary goal is to determine if higher mortality is related to TNBC over 
all other subtypes of breast cancer. 
 
III. LITERATURE REVIEW 
 
The review of literature given below examines the currently known information 
related to TNBC and its potential risk when compared with other forms of breast 
cancer. The information contained comes from published journal articles, national 
and international organizations reports, and public health organization web sites and 
fact sheets. PubMed was the major database used to find and access the journal 
articles of interest.  
Breast cancer is a major contributor to incidence and mortality rates for cancer in 
the United States. This is largely due to the increasing number of women who have 
many risk factors for breast cancer. These factors include younger age of first 
menarche, later age of first pregnancy, lower number of overall pregnancies, shorter 
time or no time spent breastfeeding, and a later age of menopause (Howell, et al., 
	  
2014; Turkoz, et al., 2013). Other factors that have been shown to contribute to the 
risk of breast cancer include age and family history. Studies have shown links for 
both of these risk factors related to all breast cancer types collectively (Turkoz, et al., 
2013). However, little work has been done specifically examining the effects of age 
and family history on TNBC patients. One study found that a higher proportion of 
patients with family history were found within the TNBC patients over the other 
breast cancer subtypes, but the results were not significant (Turkoz, et al., 2013).  
Because of their lack of receptor expression, TNBC tumors are more difficult to 
treat with targeted therapy, and are mainly treated with cytotoxic chemotherapy 
(Bae, et al., 2016; Elias, 2010; Reyes, et al., 2017). Some (but few) studies have 
examined the risk of TNBC compared to other subtypes of breast cancer and have 
found that TNBC patients have poorer survival rates (Kawai, et al., 2014; Turkoz, et 
al., 2013). These studies also showed that there is a poorer survival rate for non-
Hispanic black women than for all other women with TNBC (Elias, 2010; Kawai, et 
al., 2014). There have been mixed results relating to smoking and risk of breast 
cancer. One review found that current smokers had a 15%-40% increased risk of 
premenopausal breast cancer (Johnson, et al., 2011; Kawai, et al., 2014). Some 
studies have examined the effect of smoking on breast cancer tumor by subtype but 
did not appear to show a link between smoking and the risk of TNBC (Kawai, et al., 
2014). 
Studies have also examined the effects of marital status on mortality rates in 
breast cancer. One study found that unmarried individuals diagnosed with breast 
cancer had higher mortality risk than married breast cancer patients (Martinez, et al., 
	  
2017). This shows that marital status may have an important relationship with 
mortality among female cancer patients, but it does not examine if this risk differs 
among the different subtypes of breast cancer.  
Due to the aggressive nature of TNBC and the greater likelihood of this subtype 
affecting young women, the risk factors associated with TNBC need to be further 
examined to determine which factors may be more likely to lead to an increased risk 
of death with TNBC. There are few studies that examine the effects of family history, 
marital status, menopausal status at diagnosis, and family history on the risk of 
death due to TNBC or if there are differences in the factors associated with TNBC 
compared to other subtypes of breast cancer. 
 
 
IV. SPECIFIC AIMS 
 
To provide additional information related to covariates associated with risk of 
death in TNBC patients.  
 
V. OBJECTIVES 
 
To determine whether an association exists between the risk of death in TNBC 
patients and race, age, tobacco use, family history, marital status, insurance status, 
menopausal status and stage at diagnosis.  
To determine whether there is a difference in survival for TNBC patients when 
compared to all patients with other subtypes of breast cancer.  
 
 
 
 
 
	  
VI. METHODS 
 
Study Design 
 
This study is a retrospective cross-sectional study that uses secondary data. 
All data related to type of breast cancer, race, tobacco use, age at diagnosis, family 
history, marital status, insurance status, menopausal status at diagnosis, stage at 
diagnosis and survival status was available at the individual patient level.  
 
Study Population 
 
The study population consists of Kentucky women, age 18 and older that 
have been diagnosed with any form of breast cancer so long as the specific 
molecular subtype is known. The data consists of cases diagnosed from 2009 to 
2014, as this is when the Kentucky Cancer Registry (KCR) began recording the 
specified subtype of TNBC. KCR is an ongoing, population-based cancer registry 
that is specific to the state of Kentucky. It is designed to collect and analyze cancer 
patient information related to diagnosis and treatment. KCR contacts cases at least 
once a year to obtain data related to health, vital status, and disease progression.  
There were 18,456 cases of breast cancer diagnosed and recorded by KCR 
during the five-year period. Cases with unknown or undocumented subtype were 
excluded (n=5,035), resulting in 13,421 cases of breast cancer eligible for inclusion. 
As there were very few individual cases identified under race categories other than 
white or black, race was sorted into only those two categories. Excluding cases 
recorded as unknown or of other races (n=121) left 13,300 breast cancer cases. 
Those with unknown tobacco use were excluded (n=1,718), as well as those with 
	  
unknown family history (n=1,651), unknown menopausal status (n=1,016), and 
unknown marital status were excluded (n=112), and those with unknown insurance 
payer status were excluded (n=18). Finally, those with unknown stage of cancer at 
diagnosis were excluded (n=55). 
After the exclusions stated above, the final study population consisted of 
8,730 cases of breast cancer: 1,145 cases of triple negative breast cancer and 7,585 
cases of all other types of breast cancer. The University of Kentucky Institutional 
Review Board reviewed and approved the study protocol.   
 
Outcome Assessment 
 
Records pertaining to breast cancer cases that were reported to the Kentucky 
Cancer Registry were used. The CS site-specific factor 16 was used to determine 
the subtype of cancer as being triple negative or all other subtypes. The TNBC 
cases were then analyzed with the covariates of interest and the known patient 
status (dead or alive).  
 
Demographic Covariates 
 
Besides the assessment of breast cancer subtype, the covariates of interest 
in the breast cancer patients are race, age at diagnosis, tobacco use, family history, 
marital status, insurance status and menopausal status at diagnosis. Race has been 
limited to white and black groupings and tobacco use has been grouped into never 
used tobacco and users of any type of tobacco. Marital status has multiple 
categories: single, married, separated or divorced, widowed, and unmarried or with 
domestic partner. Family history was grouped into known family history or no family 
	  
history. Insurance status has been grouped into a total of four categories: uninsured, 
privately insured, receives Medicaid, and receives Medicare. Menopausal status has 
been grouped into pre-menopausal and post-menopausal. Stage at diagnosis has 
been reduced to two categories: early stage and late stage. Stages 0, 1, and 2 are 
grouped under the early category and stages 3 and 4 are grouped under the late 
category. All covariates used were chosen based on previous literature and the 
possibility of the covariates linked with specific breast cancer types.  
 
Statistical Methods 
 
Univariate analysis was used to report the characteristics of the entire study 
population and to determine the characteristics of the study population separated by 
cancer subtype. Chi-square and logistic regression models were used to determine 
the odds of survival related to TNBC and the covariates of interest. The relationship 
between the covariates and survival was analyzed with both bivariate and 
multivariate analysis. Statistically significant relationships in the bivariate and logistic 
regression were determined with chi-square tests (p ≤ 0.05). Survival status for the 
breast cancer cases based on the cancer subtype was determined by survival 
curves. Cox proportional-hazard regression was used to determine the risk of death 
due to breast cancer using the following covariates: race, age at diagnosis, tobacco 
use, family history, marital status, insurance status, and menopausal status at 
diagnosis. Death was documented through February 2017 with cases of last contact 
of more than one year being censored. Survival interval was used as the time 
component and was determined from date of diagnosis to date of death (or last 
contact in censoring).  
	  
Statistical significance was determined using a p-value ≤ 0.05. All analyses 
were carried out using SAS 9.4® (SAS Institute, Inc.; Cary, NC). Data used in this 
publication were provided by the Kentucky Cancer Registry, Lexington, Kentucky.  
 
VII. RESULTS 
 
The majority of the patients included in the study were white (92.68%) non-
tobacco users (56.80%), without a family history of breast cancer (57.22%), and 
married (58.67%) (Table 1). Most of the patients were privately insured or covered 
with Medicaid or Medicare, with very few being uninsured (2.16%). A large majority 
of all patients also were documented as being post-menopausal at diagnosis 
(76.60%), diagnosed at an early stage (83.89%) and were currently determined to 
be living (86.43%). Of all the documented cases of breast cancer included in the 
study, 13.12% of these cases were categorized as triple negative. 
The characteristics of the patient population specific to TNBC and all other 
subtypes are given in Table 2. The TNBC population, compared to the population of 
patients with other breast cancer subtypes, was more likely to include black women 
(11.53% vs. 6.68%), women with private insurance (53.62% vs. 48.69%), women on 
Medicaid (10.74% vs. 7.49%), and more diagnosed at a late stage (19.74% vs. 
15.56%). On average, the age of the TNBC patients included in the study population 
was 58.2 ± 12.8 years old, while the age of the patients with other breast cancer 
subtypes was 61.5 ± 12.7 years old.  
Bivariate analysis was used to determine significant association of covariates 
and death for patients with TNBC (Table 3). The results showed that race and family 
	  
history were not associated with death among women with TNBC. Whereas, tobacco 
use, age at diagnosis, marital status, primary payer status, menopausal status and 
stage at diagnosis were significantly associated with death. For example, 75.79% of 
tobacco users were survivors compared to 81.16% of non-tobacco users.  
The point estimates for the odds ratios with 95% confidence intervals 
obtained through logistic regression are given in Table 4. The odds ratios are based 
on data for TNBC patients, excluding all other cancer subtypes in the study 
population. Of the ratios showing statistical significance, women who were widowed 
had 1.70 (95% CI: 1.06, 2.72) times the odds of dying with TNBC when compared to 
married women. Women who were on Medicare had 2.59 (95% CI: 1.49, 4.51) times 
the odds of dying with TNBC when compared to privately insured women. Women 
who were uninsured had 3.04 (95% CI: 1.26, 7.35) times the odds of dying with 
TNBC when compared to privately insured women. Women who were diagnosed at 
a late stage had 9.46 (95% CI: 6.62, 13.53) times the odds of dying with TNBC when 
compared to women who were diagnosed at an earlier stage. The c value for the 
model was 0.803, meaning that the model has adequate discriminatory accuracy 
(Chen, et al., 2003; Howell, et al., 2014).  
Logistic regression was also used to determine the odds ratios with 95% 
confidence intervals for the odds of dying based on breast cancer subtype. The 
results were statistically significant and show that patients diagnosed with TNBC 
have 2.24 (95% CI: 1.90, 2.64) times the odds of dying than patients diagnosed with 
other breast cancer subtypes. 
	  
The survival curve given in Figure 1 shows the differences in survival rates 
between patients with TNBC and patients with all other subtypes of breast cancer. 
Both the log-rank test (p<0.0001) and the Wilcoxon test (p<0.0001) show a 
statistically significant difference between the two curves, meaning that those with 
TNBC have a lower probability of survival than those with other breast cancer 
subtypes. The survival curve given in Figure 2 shows the differences in survival 
rates for TNBC patients who were married, single, separated or divorced, or 
widowed. Both the log-rank test (p<0.0001) and the Wilcoxon test (p=0.0002) show 
a statistically significant difference between the curves. The survival curve in Figure 
3 shows the differences in survival rates for TNBC patients who were privately 
insured, on Medicaid, on Medicare, or who were uninsured. Both the log-rank test 
(p<0.0001) and the Wilcoxon test (p<0.0001) show a statistically significant 
difference between the curves. The survival curve in Figure 4 shows the differences 
in survival rates for TNBC patients who were diagnosed at an early stage or at a late 
stage. Both the log-rank test (p<0.0001) and the Wilcoxon test (p<0.0001) show a 
statistically significant difference between the curves.  
Two Cox regressions were estimated, one with all breast cancer subtypes to 
test the hazard of death for TNBC versus all other subtypes, and a second to test 
the impact of the covariates on TNBC patients only (Table 5). The statistically 
significant results showed that patients with TNBC had 1.78 (95% CI: 1.55, 2.06) 
times the hazard of dying when compared to patients with all other breast cancer 
subtypes. The results of the cox regression for TNBC only patients are given in 
Table 6. Of the hazard ratios showing statistical significance for those diagnosed 
	  
with TNBC, single women have 1.63 (95% CI: 1.06, 2.50) times the hazard of dying 
when compared to married women. Women on Medicaid have 1.81 (95% CI: 1.13, 
2.88) times the hazard of dying when compared to privately insured women. Women 
on Medicare have 2.73 (95% CI: 1.77, 4.20) times the hazard of dying when 
compared to privately insured women, and uninsured women have 2.98 (95% CI: 
1.57, 5.68) times the hazard of dying when compared to privately insured women. 
Women diagnosed as late stage have 6.54 (95% CI: 5.03, 8.49) times the hazard of 
dying when compared to women diagnosed as early stage.   
 
 
VIII. DISCUSSION 
 
Primary Findings 
 
This study was used to examine the potential risks associated with TNBC and 
death from TNBC. It assessed the association of TNBC with race, tobacco use, 
family history, marital status, primary payer status, menopausal status at diagnosis, 
and stage at diagnosis. All cancer cases in Kentucky over a five-year period were 
analyzed with cases being grouped by breast cancer subtype. 
The results suggest that the TNBC cases had an overall lower age than all other 
subtypes (58.2 vs. 61.5). Characteristics that may be associated with lower age also 
are seen to differ in TNBC cases: with a slightly larger percentage of TNBC patients 
being single (10.57% vs. 9.29%) and being on Medicaid (10.74% vs. 7.49%). There 
were also fewer TNBC patients widowed (13.71% vs. 17.75%) and on Medicare 
(32.58% vs. 41.79%). These noted differences in age, as well as the hazard of death 
	  
associated with late stage diagnosis (HR: 6.54; 95% CI: 5.03, 8.49), support the 
current standards of beginning mammography screening at the slightly younger age 
of 40 (Breast Cancer, 2016). 
The results showed many covariates being significantly associated with death in 
the bivariate analyses (Table 3) but age at diagnosis, tobacco use, and menopausal 
status were no longer significant in the multivariate analysis. Further studies can be 
compared to these results to see if the results are corroborated in populations other 
than Kentucky.  
The results also show that married woman had a lower risk of TNBC and lower 
hazard of dying than women that were single, widowed, or separated or divorced. 
This may be due to health factors related to happiness and companionship or due to 
the fact that a partner may help notice signs and obtain treatment early on if this is a 
factor. Insurance status also appears to be significantly related to TNBC diagnosis 
with privately insured women having a lower risk of TNBC than women who are 
uninsured, on Medicaid, or on Medicare. This may be related to the SES of the 
women as those who are privately insured generally have a higher economic 
standing than those who are uninsured, on Medicaid, or on Medicare.  
 
Comparison with Other Studies 
 
 The percentage of the study population diagnosed with TNBC support the 
numbers found in other studies, this study found those with TNBC to account for 
13.12% of the population and other sources generally found it to be between 10%-
20% (U.S. Cancer Statistics Working Group, 2016; Reyes, et al., 2017). Previous 
studies, and this current study did not find significant links between family history 
	  
and risk of TNBC or between smoking and risk of TNBC (Turkoz, et al., 2013). 
However, this current study examined additional covariates not found in Turkoz, et 
al. (2013) to add to its understanding of associated risk factors.  
 Other studies contribute to the understanding of smoking and risk of breast 
cancer, our study found smoking to be significantly associated with the risk of death, 
in the bivariate analysis only. This supports the findings in the Kawai, et al. study, in 
their multivariate analyses; they did not find a significantly increased risk of TNBC in 
patients with a smoking history (Kawai, et al., 2014). Further examination would be 
needed to support this with the inclusion of other confounders.  
 Payer status has been shown in previous studies to be significantly related to 
survival status, this is likely due to payer status being a known barrier to access to 
treatment (Shi, et al., 2015). The study found that higher mortality was associated 
with breast cancer patients on Medicaid or with no insurance (Shi, et al., 2015). Our 
study went further by separating the breast cancer cases by subtype and found that 
Medicaid, Medicare, and uninsured TNBC patients had a significantly higher risk of 
death than privately insured patients. This furthers the Shi, et al. study in that 
primary payer status is related to aggressive breast cancer and mortality rates.  
 Studies have examined marital status and its association with breast cancer. 
One study found that unmarried breast cancer patients had significantly higher risk 
for death than married patients (Martinez, et al., 2017). Although not all of our 
findings were significant, they did show an increased risk of death for patients that 
were single, widowed, and separated or divorced when compared to married 
patients. Our findings were significant in showing an increased hazard of dying for 
	  
patients who were single or widowed when compared with married patients. These 
results add support to the Martinez, et al. study and show the need for further 
studies to determine if there is significant association between the risk of death from 
TNBC and marital status.  
 The survival curves presented in Figure 1 add further support to the 
knowledge that TNBC is a more aggressive subtype of breast cancer (Bae, et al., 
2016; Elias, 2010; U.S. Cancer Statistics Working Group, 2016). The TNBC curve 
showed a significantly lower probability of survival than the curve for all other breast 
cancer subtypes.  
 
Strengths and Limitations 
 
A strength of this study is the relatively large sample size used for analysis as 
other studies found in the literature had much lower sample sizes. A large sample 
size gives strength to the results of the analysis. This study also provided 
information related to covariates specific to TNBC that has not been shown in other 
studies. This is a strength because the study was able to contribute new 
understanding to the issues of breast cancer and the TNBC subtype.  
This study also had several limitations. The study only examined 
retrospective data and did not have information related potential changes in 
screening methods over time. If women began screening earlier or later during the 
time period, this could have affected the recorded age at diagnosis. The study also 
did not examine the cancer cases by treatment used or comorbidities. These factors 
may have an effect on mortality and could provide useful information in a future 
study. Another limitation may be from the use of marital status at diagnosis in the 
	  
study. The results on survival are based on this variable but they do not show if an 
individual’s marital status changed from diagnosis to death, which may have had an 
effect on the health of the patient. Further, more factors may have been examined 
as possible risk factors for TNBC in this study to improve the understanding of what 
is a risk factor for diagnosis of TNBC or a risk factor for increased death due to 
TNBC. Other factors of interest in studies that may have been used include obesity 
and diabetes.  
 
Conclusions 
 
 This study contributes to the understanding of risk factors related to TNBC 
and the need for continued early screening and treatment to help reduce the 
mortality rates of TNBC. The covariates and outcomes in this study are only a few of 
those of interest and further examination of risk related to diagnosis of TNBC and 
death due to TNBC is needed. Overall, screening is key as TNBC is aggressive and 
leads to higher mortality; early diagnosis and treatment may be beneficial to a 
reduction in these rates.  
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XII. APPENDIX 1: FIGURES & TABLES 
Table 1: Characteristics of patients diagnosed with breast cancer between  
     2009-2014 in the study population. 
Variables N % 
Age   
          Mean (Standard Deviation) 8730 61.089 (12.805) 
Race 
          White 
          Black 
8091 
639 
92.68% 
7.32% 
Tobacco Use 
          Never Used 
          Used Any Tobacco 
4939 
3756 
56.80% 
43.20% 
Family History   
          Yes 
          No 
 3735 
4995 
42.78% 
57.22% 
Marital Status   
          Single 
          Married 
          Separated or Divorced 
          Widowed 
          Unmarried or Domestic Partner 
826 
5122 
1263 
1503 
16 
9.46% 
58.67% 
14.47% 
17.22% 
0.18% 
Primary Payer 
          Uninsured 
          Privately Insured 
          Medicaid 
          Medicare 
189 
4307 
691 
3543 
2.16% 
49.34% 
7.92% 
40.58% 
Menopausal Status at Diagnosis 
          Pre-Menopausal 
          Post-Menopausal 
2043 
6687 
23.40% 
76.60% 
Vital Status 
          Alive 
          Dead 
7545 
1185 
86.43% 
13.57% 
Breast Cancer Subtype 
          Triple Negative 
          All Other Subtypes 
1145 
7585 
13.12% 
86.88% 
Stage at Diagnosis   
          Early 
          Late 
7324 
1406 
83.89% 
16.11% 
	  
	  
	  
Table 2: Characteristics of the patient population separated by subtype. 
 TNBC Other Subtypes 
Variables N % N % 
Age 
          Mean (Standard Deviation) 1145 58.211 (12.848) 7585 61.523 (12.743) 
Race 
          White 
          Black 
1013 
132 
88.47% 
11.53% 
7078 
507 
93.32% 
6.68% 
Tobacco Use 
          Never Used 
          Used Any Tobacco 
637 
504 
55.83% 
44.17% 
4302 
3252 
56.95% 
43.05% 
Family History 
          Yes 
          No 
510 
635 
44.54% 
55.46% 
3225 
4360 
42.52% 
57.48% 
Marital Status 
          Single 
          Married 
          Separated or Divorced 
          Widowed 
          Unmarried or Domestic Partner 
121 
698 
169 
157 
0 
10.57% 
60.96% 
14.76% 
13.71% 
0% 
705 
4424 
1094 
1346 
16 
9.29% 
58.33% 
14.42% 
17.75% 
0.21% 
Primary Payer 
          Uninsured 
          Privately Insured 
          Medicaid 
          Medicare 
35 
614 
123 
373 
3.06% 
53.62% 
10.74% 
32.58% 
154 
3693 
568 
3170 
2.03% 
48.69% 
7.49% 
41.79% 
Menopausal Status at Diagnosis 
          Pre-Menopausal 
          Post-Menopausal 
308 
837 
21.14% 
78.86% 
1735 
5850 
22.87% 
77.13% 
Vital Status     
          Alive 
          Dead 
903 
242 
78.86% 
21.14% 
6642 
943 
87.57% 
12.43% 
Stage at Diagnosis     
          Early 
          Late 
919 
226 
80.26% 
19.74% 
6405 
1180 
84.44% 
15.56% 
 
 
 
 
 
 
 
	  
Table 3: Bivariate analysis of covariates for TNBC. 
 TNBC Chi-Square 
Dead (%) Alive (%) (p-value) 
    
Race           
Black 
White 
19.70% 
21.32% 
80.30% 
78.68% 
 
0.6669 
Tobacco Use  
Never Used 
Used Tobacco 
18.84% 
24.21% 
81.16% 
75.79% 
 
0.0276 
Family History  
No 
Yes 
22.36% 
19.61% 
77.64% 
80.39% 
 
0.2565 
Age at Diagnosis  
23-39 
40-64 
65+ 
16.46% 
15.52% 
33.62% 
83.54% 
84.48% 
66.38% 
 
 
<0.0001 
Marital Status  
Married 
Separated or Divorced 
Single 
Widowed 
16.62% 
23.67% 
25.62% 
35.03% 
83.38% 
76.33% 
74.38% 
64.97% 
 
 
 
<0.0001 
Primary Payer Status  
Privately Insured 
Medicaid 
Medicare 
Uninsured 
11.73% 
21.95% 
35.39% 
31.43% 
88.27% 
78.05% 
64.61% 
68.57% 
 
 
 
<0.0001 
Menopausal Status  
Pre-Menopausal 
Post-Menopausal 
13.31% 
24.01% 
86.69% 
75.99% 
 
<0.0001 
Stage at Diagnosis    
Early 
Late 
12.73% 
55.31% 
87.27% 
44.69% 
 
<0.0001 
	  
Table 4: Odds ratio estimates for TNBC patients (calculated with logistic 
     regression) 
Effect Point Estimate 95% Confidence Limits 
Race:  
          Black vs. White 
 
0.788 
 
0.452 
 
1.375 
Tobacco Use:  
          Never Used vs. Cigarettes Smoker 
 
0.764 
 
0.545 
 
1.070 
Family History:  
          Yes vs. No 
 
1.084 
 
0.774 
 
1.518 
Age at Diagnosis: 
          40-64 vs. 23-39 
          65+ vs. 23-39 
 
0.697 
1.022 
 
0.316 
0.382 
 
1.536 
2.731 
Marital Status:  
          Single vs. Married 
          Separated or Divorced vs. Married 
          Widowed vs. Married 
 
1.424 
1.505 
1.698 
 
0.804 
0.935 
1.062 
 
2.524 
2.423 
2.715 
Primary Payer:  
          Uninsured vs. Privately Insured 
          Medicaid vs. Privately Insured 
          Medicare vs. Privately Insured 
 
3.037 
1.447 
2.593 
 
1.255 
0.810 
1.491 
 
7.349 
2.586 
4.509 
Menopausal Status at Diagnosis:  
          Post-Menopausal vs. Pre-Menopausal 
 
1.438 
 
0.866 
 
2.387 
Stage at Diagnosis:  
          Late vs. Early 
 
9.462 
 
6.616 
 
13.531 
 
 
 
 
 
 
 
 
	  
Figure 1: Survival curve comparing the survival over time (in years) of TNBC 
       and all other breast cancer subtypes 
	  
 
 
 
 
 
 
 
 
 
 
 
	  
Figure 2: Survival curve comparing the survival over time (in years) for all  
       TNBC patients based on marital status 
 
 
 
 
 
 
 
 
 
 
 
 
	  
Figure 3: Survival curve comparing the survival over time (in years) for all  
       TNBC patients based on insurance status.  
 
 
 
 
 
 
 
 
 
 
 
 
	  
Figure 4: Survival curve comparing the survival over time (in years) for all 
TNBC patients based on stage at diagnosis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
	  
Table 5: Hazard ratios for TNBC patient data. 
 Pr > 
ChiSq 
Hazard 
Ratio 
95% Confidence 
Limits 
Age at Diagnosis: 40-64 
                                65+ 
0.4983 
0.8227 
0.797 
0.913 
0.414 
0.412 
1.536 
2.025 
Race: Black 0.3806 0.825 0.536 1.269 
Tobacco Use: Never Used Tobacco 0.0817 0.794 0.612 1.030 
Family History: Yes 0.9023 0.984 0.757 1.278 
Marital Status at Diagnosis: Single 
                                                Widowed 
                                                Separated or Divorced 
0.0253 
0.1280 
0.1078 
1.628 
1.310 
1.356 
1.062 
0.925 
0.936 
2.497 
1.855 
1.966 
Primary Payer: Medicaid 
                           Medicare 
                           Uninsured 
0.0128 
<0.0001 
0.0009 
1.805 
2.725 
2.983 
1.134 
1.767 
1.568 
2.875 
4.203 
5.677 
Menopausal Status at Diagnosis: Post-menopausal 0.1117 1.411 0.923 2.156 
Stage at Diagnosis: Late Stage <0.0001 6.535 5.033 8.486 
 
